Monday, December 29, 2014

Top 5 Healthcare Equipment Stocks To Invest In Right Now

Popular Posts: The Top 10 S&P 500 Dividend Stocks for March5 Stocks to Sell for July5 Stocks to Buy for July Recent Posts: Citigroup Stock Shrugs Off $7B Fine 5 Low-Beta, High-Yield Dividend Stocks for a Market Crash 3 Tech Stocks in Need of Street-Beating Earnings — YHOO, EBAY, GOOGL View All Posts Citigroup Stock Shrugs Off $7B Fine

Citigroup (C) earnings reported Monday were hardly a thing of beauty — not after agreeing to pay a $7 billion fine — but better-than-expected trading revenue helped adjusted profit beat Wall Street forecasts, and that boosted Citigroup stock in early trading.

5 Best Dividend Stocks For 2015: China Biologic Products Inc.(CBPO)

China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People?s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and sec ondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company?s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

  • [By Jake L'Ecuyer]

    Leading and Lagging Sectors
    Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

Top 5 Healthcare Equipment Stocks To Invest In Right Now: Comtech Telecommunications Corp.(CMTL)

Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers. The Telecommunications Transmission segment provides satellite earth station equipment and systems, over-the-horizon microwave systems, and forward error correction technology, which are used in various commercial and government applications, including backhaul of wireless and cellular traffic, broadcasting (including HDTV), IP-based communications traffic, long distance telephony, and secure defense applications. The Mobile Data Communications segment provides mobile satellite transceivers, and computers and satellite earth station network gateways and associated installation, training, and maintenance services; supplies and operates satellite pac ket data networks, including arranging and providing satellite capacity; and offers microsatellites and related components. The RF Microwave Amplifiers segment designs, develops, manufactures, and markets satellite earth station traveling wave tube amplifiers (TWTA) and broadband amplifiers. Its amplifiers are used in broadcast and broadband satellite communication; defense applications, such as telecommunications systems and electronic warfare systems; and commercial applications comprising oncology treatment systems, as well as to amplify signals carrying voice, video, or data for air-to-satellite-to-ground communications. The company serves satellite systems integrators, wireless and other communication service providers, broadcasters, defense contractors, military, governments, and oil companies. Comtech markets its products through independent representatives and value-added resellers. The company was founded in 1967 and is headquartered in Melville, New York.

Advisors' Opinion:
  • [By Dividends4Life]

    Comtech Telecommunications Corp. (CMTL) designs, develops, produces, and markets products, systems, and services for communications solutions. December 9th the company increased its quarterly dividend 9.1% to $0.30 per share. The dividend is payable February 19, 2014, to stockholders of record on January 17, 2014. The yield based on the new payout is 3.6%.

  • [By Monica Gerson]

    Comtech Telecommunications (NASDAQ: CMTL) reported upbeat fiscal fourth quarter results and issued a strong full-year outlook. Comtech shares jumped 11.12% to $26.77 in the after-hours trading session.

Top 5 Healthcare Equipment Stocks To Invest In Right Now: Alamos Gold Inc (AGI)

Alamos Gold Inc. is engaged in the acquisition, exploration, development and extraction of precious metals in Mexico and Turkey. It owns and operates the Mulatos mine (Mulatos or the Mine) and holds the mineral rights to the Salamandra group of concessions in the State of Sonora, Mexico. The Mulatos mine is approximately 220 kilometers by air east of the City of Hermosillo. In addition, the Company owns the Agi Dagi and Kirazli advanced-stage gold development projects located in the Biga Peninsula of northwestern Turkey. Agi Dagi is located about 50 kilometers southeast of Canakkale, and Kirazli is located approximately 25 kilometers northwest of Agi Dagi. In January 2013, it acquired 14.3% interest of Aurizon Mines Ltd. (Aurizon). In August 2013, the Company acquired Esperanza Resources Corp. In September 2013, the Company announced that it has completed the acquisition of Orsa Ventures Corp. Advisors' Opinion:
  • [By Jon C. Ogg]

    Alamos�Gold Inc. (NYSE: AGI) was reinstated as Buy with a target price of $21 in Canada, which would translate to closer to $20 in U.S. share prices (versus $16.33 current), at BofA/Merrill Lynch.

Top 5 Healthcare Equipment Stocks To Invest In Right Now: SilverCrest Mines Inc (SVLC)

SilverCrest Mines Inc. (SilverCrest), incorporated on May 22, 1973, is engaged in the acquisition, exploration and development of mineral properties in Mexico and Central America. The Company�� principal focus is the development and operation of the Santa Elena Project, which property consists of seven mineral concessions totaling 2,726.54 hectares, portions of which include the producing Santa Elena gold and silver mine located northeast of Hermosillo, Sonora State, Mexico. It operates in three segments: the mine operations at Santa Elena, Mexico; mine exploration and evaluation projects at La Joya and Cruz de Mayo, Mexico, and Corporate. The Company is also focused on exploring and developing its La Joya Property located in Durango, Mexico, which contains a discovered polymetallic deposit. The Company�� other mineral properties include the Cruz de Mayo Project (Mexico), the La Joya Property (Mexico), the Silver Angel Project (Mexico) and the El Zapote Project (El Salvador).

The La Joya Property consists of 14 mineral concessions with a total area of approximately 8,379.6 hectares. Its Cruz de Mayo Project consists of two mineral concessions comprising a total of 452 hectares. The Company holds a 100% interest in the Cruz de Mayo 2 concession (which encompasses 434 hectares). The Silver Angel Project consists of two mineral concessions encompassing a total of 3,251 hectares located in the northern Sierra Madre Range in Sonora, Mexico. The Company holds a 100% interest in these concessions, which were acquired by concession applications.

The El Zapote Project consists of two mineral concessions (the El Caliche and San Juan Exploration Concessions) located in the Department of Santa Ana in northern El Salvador, Central America. The Company holds a 100% interest in the El Zapote Project. During the year ended December 31, 2011, an initial drill program of 25 holes totaling approximately 2,900 meters was completed on the Santa Elena Norte target, located approximately 1 kilo! meters north of the Santa Elena Mine.

Advisors' Opinion:
  • [By Hebba Investments]

    Even with rising Q2 costs, GG still has lower true all-in costs than many of its larger competitors' Q1FY13 costs. Compared to Q1FY13 numbers of competitors such as Yamana Gold (AUY) (costs just over $1300), Kinross Gold (KGC) (costs above $1350), Silvercrest Mines (SVLC) (costs below $1100), Newmont Gold (NEM) (costs around $1300) Agnico-Eagle (AEM) (costs around $1400) and Barrick Gold (ABX) (costs around $1200).

No comments:

Post a Comment